Mark Jennings is crypto exchange Gemini’s Europe CEO. Opinions are his own.One year after its implementation, and with over 100 firms already authorised as cryptoMark Jennings is crypto exchange Gemini’s Europe CEO. Opinions are his own.One year after its implementation, and with over 100 firms already authorised as crypto

Gemini: EU lawmakers must listen to crypto industry or risk stifling innovation

3 min read

Mark Jennings is crypto exchange Gemini’s Europe CEO. Opinions are his own.

One year after its implementation, and with over 100 firms already authorised as crypto asset service providers, the European Union’s Markets in Crypto-Assets regulation, or MiCA, has proven itself as the world’s first comprehensive crypto rulebook and a much-needed part of Europe’s regulatory landscape.

Gemini: EU lawmakers must listen to crypto industry or risk stifling innovation

Competing jurisdictions are already implementing lessons learned from MiCA, including the UK Government’s crypto roadmap, stablecoin reserve requirements within the US’ Genius Act, and Hong Kong’s Stablecoins Bill.

Yet it’s far from perfect.

Uncertainty around MiCA’s future supervisory oversight, along with unclear guidelines and burdensome requirements, risks stifling innovation.

For MiCA to become one of the world’s most robust regulatory frameworks, policymakers must fix the current regime’s drawbacks, incorporate industry feedback and offer clarity, whilst considering how supervision is structured within a “MiCA 2.0.”

Supervisory structure

The European Securities and Markets Authority, or ESMA, recently signalled its intent to take over centralised supervision of all CASPs, prompting contrasting reactions across the EU.

Regardless of which authority oversees MiCA, it’s vital that we’re regulated by someone with sufficient expertise, resources, and understanding of fast-evolving crypto business models.

EU member states have already built much of this regulatory experience, so any move towards centralisation should preserve this.

Furthermore, firms regulated under Markets in Financial Instruments Directive, or MiFID, and Payment Services Directive, or PSD, will remain supervised at the national level.

Centralised supervision would therefore create problems for those holding several licenses, as they would be subjected to multiple reporting lines.

This is an avoidable burden when streamlined.

Indeed, cross-border rules are essential for European firms to maintain competitiveness.

Clarifying MiCA’s Jurisdiction

ESMA must incorporate industry feedback to ensure that regulation is effectively guided.

Greater clarity is essential regarding MiCA’s scope, as existing rules don’t adequately cover emerging use cases such as tokenised real-world assets, staking, and yield-bearing products.

MiCA 2.0 should include rules defining the boundary between MiCA and frameworks for payments and investment services, such as PSD and MiFID.

Further guidance is also required on market-structure issues, including shared order books and hybrid execution models, to allow companies to design compliant business models.

Stablecoins: A key battle

Stablecoins will play a central role in the future payments infrastructure, and it’s crucial that MiCA establishes clarity on their use and issuance.

At present, stablecoins are marred by regulatory ambiguity, adversely affecting users, issuers and CASPs — with many issuers receiving fines for rule violation.

While the January 2025 ban on non-MiCA-compliant stablecoins was intended to protect customers, it triggered frantic liquidations, leading to fragmented liquidity.

Additionally, greater definition is needed on multi-issuance models, redemption responsibilities, and reserve standards to ensure the EU’s stablecoin framework addresses risks, while Euro-denominated stablecoin use grows.

Maintaining global competitiveness

If Europe intends to preserve its regulatory leadership, MiCA 2.0 must deliver clear, proportionate regulations that are consistently applicable across all member states.

Allowing time for successful solutions to MiCA’s issues, not just supervisory adjustments, can secure Europe’s competitive advantage.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11